Antimicrobial Resistance Surveillance Market Analysis Through 2030 Focusing On Demand Trends And Growth Drivers
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Antimicrobial Resistance Surveillance Market In 2026 And How Much Will It Reach By 2030?
The antimicrobial resistance surveillance market size has experienced robust expansion in recent years. This market is projected to increase from $7.3 billion in 2025 to $7.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.4%. Its historical development has been driven by factors such as the rise in drug-resistant infections, hospital infection control initiatives, public health surveillance programs, laboratory testing expansion, and antibiotic misuse concerns.
The antimicrobial resistance surveillance market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $10.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this growth during the forecast period include worldwide AMR monitoring initiatives, AI-powered predictive surveillance, cloud-enabled data sharing, an increase in genomic surveillance, and policy-mandated reporting requirements. Key trends expected within this period encompass real-time tracking of resistance patterns, whole genome sequencing for surveillance, AI-driven resistance analytics, unified public health databases, and comprehensive hospital-level AMR tracking systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
What Key Growth Drivers Are Influencing The Antimicrobial Resistance Surveillance Market?
The increasing prevalence of infectious diseases is set to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are illnesses stemming from harmful microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly among individuals. The escalating occurrence of these diseases is influenced by factors like climate change, urbanization, and global travel, all of which facilitate pathogen dissemination and human exposure to novel microbes. Antimicrobial resistance surveillance plays a vital role in tracking the spread of resistant pathogens, thereby guiding effective treatment strategies and informing public health policies to combat infectious diseases. As an illustration, in February 2024, the UK Health Security Agency, a UK-based government body, published a report indicating that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Consequently, the rising incidence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.
How Is The Antimicrobial Resistance Surveillance Market Examined Through Segment Analysis?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
Which Trends Are Affecting The Antimicrobial Resistance Surveillance Market Framework?
Leading companies operating in the market are concentrating on innovative technologies, such as advanced diagnostic tools, to optimize processes, enhance efficiency, improve accuracy, reduce costs, and deliver superior outcomes for patients and end-users. A diagnostic tool is any device, instrument, software, or methodology employed to identify, detect, or assess the presence of a condition, disease, malfunction, or issue. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer and supplier of services for diagnostic products, announced the launch of the PA-100 AST Point-of-Care Testing System. This system allows for rapid and accurate detection of antimicrobial resistance directly at the point of care, offering a significant reduction in time compared to traditional laboratory methods, which can span several days. By providing results in just 30 minutes, it enables clinicians to make timely and informed decisions regarding appropriate treatment for infections, thereby reducing the reliance on broad-spectrum antibiotics and aiding in the combat against the spread of antimicrobial resistance.
Which Companies Are Influencing The Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.
Access The Complete Antimicrobial Resistance Surveillance Market Report:
Which Geographic Region Represents The Largest Antimicrobial Resistance Surveillance Market Share?
North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Antimicrobial Resistance Surveillance Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance Surveillance Market 2026, By The Business Research Company
Pediatric Orthopedic Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report
Orthopedic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report
Orthopedic Regenerative Surgical Products Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
